Five Russian that are deaf intend to attempt the CRISPR gene-editing technique so they can have a biologic kid who can hear, biologist Denis Rebrikov has informed. He prepares to apply to the pertinent Russian authorities for consent in “a couple of weeks”
Feng Zhang and collaborators have used a transposon system with CRISPR that appears more specific and reliable than regular CRISPR, and without shredding the genome.
The prominent patent contest who developed a key feature of the genome editor CRISPR has been resurrected. The 3-year-old battle, which a U.S. appeals court showed up to have placed to rest in September 2018, pits parties represented by the University of California (UC) versus the Broad Institute of Cambridge, Massachusetts.
Vertex revealed plans to acquire Exonics Therapeutics for roughly $1 billion, in addition, to invest an added up-to $1.175 billion to increase a 3 1/2 year, potentially $2.5 billion-plus partnership with CRISPR Therapeutics.
Scientists at the University of Sydney have identified an antidote using CRISPR to the lethal sting provided by the most poisonous animal on the planet-- the Australian box jellyfish.
Vertex revealed plans to acquire Exonics Therapeutics for roughly $1 billion, in addition, to invest an added up-to $1.175 billion to increase a 3 1/2 year, potentially $2.5 billion-plus partnership with CRISPR Therapeutics.
Five Russian that are deaf intend to attempt the CRISPR gene-editing technique so they can have a biologic kid who can hear, biologist Denis Rebrikov has informed. He prepares to apply to the pertinent Russian authorities for consent in “a couple of weeks”
A portable device to diagnose hereditary anomalies A team of engineers hopes a brand-new device called the CRISPR-Chip might swiftly diagnose hereditary anomalies without requiring to send information to a lab. Genetics has gotten in unchartered territory at a scorching rate over the past couple of years, and currently, a group of...
Researchers from the University of California, San Francisco used a genome-scale CRISPR interference (CRISPRi) functional genomics system to methodically identify genetic interactions with a mutant type of KRAS called KRASG12C, and discovered combination treatments that target genes associated with its activity.
Researches are making use of CRISPR to change phages for treatment of drug-resistant superbugs in patients. A recent study describes the response of a 15-year-old patient with cystic fibrosis with a disseminated Mycobacterium abscessus infection.
error: Content is protected !!